Key result
Intracisternal OP-1 markedly enhances post-stroke sensorimotor recovery in rats without altering infarct volume.
Answers are grounded in this paper and cite their sources.
Osteogenic protein-1 (OP-1, BMP-7) is a member of the transforming growth factor-beta (TGF-beta) superfamily that selectively induces dendritic outgrowth from cultured neurons. We injected human recombinant OP-1 (1 or 10 micrograms) or vehicle into the cisterna magna of mature male Sprague-Dawley rats 1 and 4 days after focal cerebral infarction induced by middle cerebral artery (MCA) occlusion. OP-1 treatment was associated with a marked enhancement of recovery of sensorimotor function of the impaired forelimb and hindlimb (contralateral to infarcts) as assessed by limb placing tests. This effect appeared to be dose dependent. There was no difference in infarct volume between OP-1 and vehicle-treated rats. The mechanisms of enhanced recovery by intracisternal OP-1 may include promotion of dendritic sprouting in the intact uninjured brain.
No takes yet. Share an insight, caveat, or question.
Kawamata et al. (1998) studied Focal cerebral infarction (stroke) induced by middle cerebral artery occlusion. Intracisternal human recombinant osteogenic protein-1 (OP-1, BMP-7) vs. Vehicle was evaluated on Recovery of sensorimotor function of the impaired forelimb and hindlimb assessed by limb placing tests. Intracisternal OP-1 given 1 and 4 days post-stroke markedly enhanced sensorimotor recovery vs vehicle in rats without altering infarct volume.
Synapse has enriched 10 related papers. Consider them for comparative context: